Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ITGA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RRAGC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NXF2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WLS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGFA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LGALS3BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-DMB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCL16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEANC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFAIP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HERC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on